ENTITY
Kintor Pharmaceutical

Kintor Pharmaceutical (9939 HK)

72
Analysis
Health Care • China
Kintor Pharmaceutical is a clinical-stage biotechnology company focused on developing innovative small molecule and biological therapeutics for dermatology and oncology, including treatments for androgenetic alopecia, acne vulgaris, and various cancers. The company also develops high-end cosmetics. Kintor Pharmaceutical was founded in 2009 and is headquartered in Suzhou, People's Republic of China.
more
•21 May 2020 10:22

Kintor Pharma (å¼€ę‹“čÆäøš) IPO Trading: Limited Upside Despite Retail Chasing

Kintor Pharma raised HKD 1.7 billion (USD 225 m) from its global offering and will list on the stock exchange tomorrow. In our previous insights,...

Logo
353 Views
Share
•17 May 2020 12:55

ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
•12 May 2020 14:57

Kintor Pharma IPO: Valuation Insights

Kintor Pharmaceutical (9939 HK) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers and...

Logo
460 Views
Share
•12 May 2020 10:19

Kintor Pharma (å¼€ę‹“čÆäøš) IPO: Weak in Cornerstone but Still Expect Upside

Kintor Pharma launched book building today to raise up to USD 240 million to listing in Hong Kong. Book will be closed swiftly on Friday. In our...

Logo
627 Views
Share
bullish•Kingsoft Cloud
•10 May 2020 13:33

ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...

Share
x